Welsh, Carson, Anderson & Stowe (WCAS) Majority Stake Acquisition of LIBERTY Dental Plan Corporation
March 2, 2022
LIBERTY Dental Plan Corporation entered into a definitive agreement under which Welsh, Carson, Anderson & Stowe (WCAS) will make an equity investment and become the majority investor in LIBERTY. Anthem will also invest as a minority investor, and the transaction is expected to close later this year following customary regulatory reviews.
- Buyers
- Welsh, Carson, Anderson & Stowe (WCAS), Anthem, Inc.
- Targets
- LIBERTY Dental Plan Corporation (LIBERTY)
- Industry
- Healthcare Services
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Welsh, Carson, Anderson & Stowe Invests in Constitution Surgery Alliance
June 16, 2025
Healthcare Services
Welsh, Carson, Anderson & Stowe (WCAS) has made a strategic growth investment in Constitution Surgery Alliance (CSA), an independent developer and operator of ambulatory surgery centers. The investment will provide capital and healthcare scaling expertise to help CSA expand nationally; CSA currently manages 16 facilities across five states and performs over 100,000 procedures annually.
-
Welsh, Carson, Anderson & Stowe Acquires Majority Stake in GovernmentCIO
November 2, 2020
IT Services
Welsh, Carson, Anderson & Stowe (WCAS) completed a strategic majority investment in GovernmentCIO, a provider of technology and digital solutions to the federal health IT market. The investment will fund organic growth and support a buy-and-build strategy to expand GovernmentCIO’s capabilities and customer footprint across federal health and adjacent federal IT markets.
-
Welsh, Carson, Anderson & Stowe Acquires Majority Stake in EquiLend
January 18, 2024
Financial Services
Welsh, Carson, Anderson & Stowe (WCAS) has completed its majority acquisition of EquiLend, a global financial technology, data and analytics provider for the securities finance industry, following regulatory approvals in the U.S., UK and Ireland. Founding shareholders and customers — including Bank of America, BlackRock, Goldman Sachs, Morgan Stanley, National Bank of Canada, State Street and UBS — joined WCAS as owners; WCAS previously committed $200 million to support EquiLend's organic growth and acquisitions.
-
Welsh, Carson, Anderson & Stowe Acquires Majority Stake in Leiters
November 9, 2021
Pharmaceuticals
Welsh, Carson, Anderson & Stowe (WCAS) acquired a majority ownership stake in Leiters, an FDA-registered 503B outsourced pharmaceutical compounding provider. WCAS invested alongside health system investors including Intermountain Ventures, Novant Health, Rex Health Ventures, Spectrum Health Ventures and UNC Health, while existing investors — including Kaiser Permanente Ventures, Mayo Clinic, Frazier Healthcare Partners, SV Health Investors and H.I.G. BioHealth Partners — made reinvestments to support Leiters' growth, facility expansion and new product development.
-
Welsh, Carson, Anderson & Stowe and Walgreen Co. Invest in Shields Health Solutions
July 31, 2019
Healthcare Services
Welsh, Carson, Anderson & Stowe (WCAS) and Walgreen Co. (Walgreens) made undisclosed equity investments in Shields Health Solutions to support the company’s national expansion and growth of its integrated specialty pharmacy model. The capital will help Shields expand into new disease states and enhance integrated service and technology offerings while accelerating partnerships with health systems nationwide.
-
Welsh, Carson, Anderson & Stowe Acquires Majority Stake in AIA Contract Documents
July 9, 2025
Cloud & SaaS
Welsh, Carson, Anderson & Stowe (WCAS) has made a majority investment in AIA Contract Documents (ACD), the leading risk-management and contract workflow platform for the architecture, engineering, and construction (AEC) industry. WCAS is partnering with The American Institute of Architects (AIA) and existing investor True Wind Capital, which will remain investors and strategic partners; terms were not disclosed.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.